jcm-logo

Journal Browser

Journal Browser

The Role of Cardiac Rehabilitation After Myocardial Infarction, Coronary Artery Bypass Surgery, and in Other Cardiac Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 1 May 2026 | Viewed by 886

Special Issue Editors


E-Mail Website
Guest Editor
1. Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, 34100 Trieste, Italy
2. Department of Medical Surgical and Health Sciences, University of Trieste, 34125 Trieste, Italy
Interests: cardiovascular diseases; myocardial infarction; ischemic heart disease; cardiomyopathies; heart failure; ventricular assist device; heart transplantation; biomarkers; cytokine; inflammasome; risk stratification; vitamin D; cardiac rehabilitation; cardiac remodeling; illness perception
Special Issues, Collections and Topics in MDPI journals

E-Mail
Guest Editor
Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Department of Medical Surgical and Health Science, University of Trieste, 34149 Trieste, Italy
Interests: cardiovascular diseases; myocardial infarction; ischemic heart disease; cardiomyopathies; heart failure; ventricular assist device; heart transplantation; biomarkers; cytokine; inflammasome; risk stratification; vitamin D; cardiac rehabilitation; cardiac remodeling; illness perception
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The high prevalence of coronary artery disease and the persistently high rates of mortality and morbidity in patients following ischemic events, despite advancements in treatment protocols underscores the urgent need to implement innovative approaches that can improve patient outcomes, particularly by encouraging sustainable lifestyle changes. Cardiac rehabilitation represents a highly effective, evidence-based strategy with the potential to address these challenges; however, it remains significantly underutilized. For these reasons, we are particularly interested in exploring and advancing the role of cardiac rehabilitation in patient care.

Indeed, many studies have shown that cardiac rehabilitation significantly improves patient outcomes. Yet, only the guidelines from the American College of Cardiology and the European Society of Cardiology include cardiac rehabilitation as part of their protocols. The European guidelines advocate for initiating rehabilitation early, while the patient is still hospitalized, whereas the American guidelines recommend starting therapy approximately three weeks post-discharge. Despite its proven benefits, cardiac rehabilitation remains underutilized, largely because many patients are unaware of it, and because healthcare professionals often lack the knowledge, expertise, interest, or resources to promote and implement it effectively within hospital settings.

The aim of our Special Issue is to compile a diverse array of original research papers, meta-analyses, and comprehensive reviews that delve into the beneficial impacts of cardiac rehabilitation for patients recovering from myocardial infarction.

We seek to highlight studies that demonstrate improvements in functional recovery, quality of life, and long-term cardiovascular health. Additionally, this Special Issue will explore the molecular pathways underlying the therapeutic effects of cardiac rehabilitation, shedding light on mechanisms such as inflammation modulation, endothelial function improvement, and myocardial remodeling. By addressing both clinical and molecular perspectives, this Special Issue aims to provide a holistic view of cardiac rehabilitation's role in myocardial infarction recovery, as well as to identify potential avenues for optimizing and personalizing rehabilitation protocols for enhanced patient outcomes.

Dr. Aneta Aleksova
Dr. Milijana Janjušević
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cardiac rehabilitation

  • coronary artery disease

  • myocardial infarction

  • coronary artery bypass surgery

  • heart failure

  • ventricular assist device

  • heart transplantation

  • cardiomyopathies

  • cardiac remodeling

  • illness perception

  • treatment adherence

  • gender difference

  • biomarkers

  • endothelial function

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 1005 KB  
Article
Phase II Cardiac Rehabilitation Under Compulsory Insurance in Kazakhstan: A Five-Year Cohort Analysis of Clinical and Economic Outcomes
by Yelena Sergeyeva, Lyudmila S. Yermukhanova, Ardak N. Nurbakyt, Gulnara L. Kurmanalina, Dariush Walkowiak, Maral G. Nogayeva and Alireza Afshar
J. Clin. Med. 2025, 14(17), 6317; https://doi.org/10.3390/jcm14176317 - 7 Sep 2025
Viewed by 483
Abstract
Background/Aim of Study: Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. Cardiac rehabilitation (CR) plays a pivotal role in the recovery of post-acute myocardial infarction (AMI) patients. Despite evidence supporting its clinical benefits, CR remains underutilized, especially in middle-income [...] Read more.
Background/Aim of Study: Cardiovascular diseases (CVDs) are the leading cause of morbidity and mortality globally. Cardiac rehabilitation (CR) plays a pivotal role in the recovery of post-acute myocardial infarction (AMI) patients. Despite evidence supporting its clinical benefits, CR remains underutilized, especially in middle-income countries like Kazakhstan. This study aimed to evaluate the clinical effectiveness and economic impact of phase II CR among patients with AMI treated at the Almaty City Cardiology Center between 2018 and 2022. Methods: A retrospective cohort study was conducted using data from 2672 AMI patients. Two cohorts were compared: those who participated in phase II CR and those who did not. Primary outcomes included changes in left ventricular ejection fraction (LVEF), rehospitalization rates, and return to active work. Results: Economic outcomes involved direct medical costs related to initial hospitalization and follow-up care. CR participants showed significant improvements in LVEF (53.7% vs. 49.0% in non-CR patients, p < 0.001). Despite these clinical benefits, there was no significant reduction in long-term treatment costs between the CR and non-CR groups. CR users had slightly higher initial treatment costs but similar cumulative costs for subsequent treatments over two years. Importantly, government funding limitations were found to hinder the full effectiveness of CR programs in Kazakhstan. Conclusions: Phase II CR improves cardiac function in AMI patients but does not reduce long-term treatment costs. The current insufficient government funding for CR limits its broader impact. Expanding CR services and increasing funding are essential to maximize its benefits within Kazakhstan’s healthcare system. Full article
Show Figures

Figure 1

Back to TopTop